Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Structurally driven selection of human hepatitis C virus mimotopes.

Spiga O, Padula MG, Scarselli M, Ciutti A, Bernini A, Venditti V, Prischi F, Falciani C, Lozzi L, Bracci L, Valensin PE, Caudai C, Niccolai N.

Antivir Ther. 2006;11(7):917-22.

PMID:
17302254
2.

Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy.

Pianigiani E, Risulo M, Ierardi F, Sbano P, Andreassi L, Fimiani M, Caudai C, Valensin PE, Zazzi M.

Burns. 2006 May;32(3):348-51. Epub 2006 Mar 9.

PMID:
16529868
3.

Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients.

Sebastiani GD, Bellisai F, Caudai C, Rottoli P, Valensin PE, Pippi L, Morozzi G, Porciello G, Donvito A, Bilenchi R, Giannini F, Galeazzi M.

J Biol Regul Homeost Agents. 2005 Jan-Jun;19(1-2):17-22.

PMID:
16180280
4.

Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.

Caudai C, Pianese M, Zacchini F, Toti M, Zazzi M, Valensin PE.

J Clin Virol. 2005 Feb;32(2):151-5.

PMID:
15653418
5.

Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype.

Zazzi M, Romano L, Venturi G, Shafer RW, Reid C, Dal Bello F, Parolin C, Palù G, Valensin PE.

J Antimicrob Chemother. 2004 Feb;53(2):356-60. Epub 2003 Dec 19.

PMID:
14688053
6.

A Mediterranean arbovirus: the Toscana virus.

Valassina M, Cusi MG, Valensin PE.

J Neurovirol. 2003 Dec;9(6):577-83. Review.

PMID:
14602570
7.
8.

Serological survey of Toscana virus infections in a high-risk population in Italy.

Valassina M, Valentini M, Pugliese A, Valensin PE, Cusi MG.

Clin Diagn Lab Immunol. 2003 May;10(3):483-4.

9.

Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy.

Venturi G, Romano L, Carli T, Corsi P, Pippi L, Valensin PE, Zazzi M.

Antivir Ther. 2002 Dec;7(4):245-50.

PMID:
12553478
10.

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

Cusi MG, Zurbriggen R, Correale P, Valassina M, Terrosi C, Pergola L, Valensin PE, Glück R.

Vaccine. 2002 Oct 4;20(29-30):3436-42.

PMID:
12297388
11.

Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice.

Romano L, Peduzzi C, Venturi G, Di Pietro M, Carli T, Corsi P, Gonnelli A, Valensin PE, Zazzi M.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):533-5. No abstract available.

PMID:
12154345
12.

Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis.

Valassina M, Valentini M, Valensin PE, Cusi MG.

Diagn Microbiol Infect Dis. 2002 Jul;43(3):201-5.

PMID:
12106953
13.

Helicobacter pylori infection and infertility.

Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D, Peris C, Lotano MR, Gennari L, Bianciardi L, Renieri T, Valensin PE, Capitani S, Moretti E, Colapinto R, Baccetti B, Gennari C.

Eur J Gastroenterol Hepatol. 2002 Jun;14(6):663-9.

PMID:
12072601
14.

Lack of efficacy of ozone therapy in HIV infection.

Bocci V, Venturi G, Catucci M, Valensin PE, Zazzi M.

Clin Microbiol Infect. 1998 Jan;4(11):667-669. No abstract available.

15.

Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.

Romano L, Venturi G, Giomi S, Pippi L, Valensin PE, Zazzi M.

J Med Virol. 2002 Feb;66(2):143-50.

PMID:
11782921
16.

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes.

Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D, Nencini C, Valensin PE, Petrioli R, Giorgi G, Zurbriggen R, Gluck R, Francini G.

Eur J Cancer. 2001 Nov;37(16):2097-103.

PMID:
11597390
17.

Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route.

Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Glück R.

Arch Virol. 2001 Jul;146(7):1241-8.

PMID:
11556703
18.

Long-term follow-up of human herpes virus 6 infection in autologous bone marrow transplant recipients.

Galieni P, Moschettini D, Donati D, Tozzi M, Valensin PE, Lauria F.

Haematologica. 2001 Jul;86(7):782-3. No abstract available.

19.

Helicobacter pylori cagA and vacA types and gastric carcinoma.

Figura N, Valassina M, Roviello F, Pinto F, Lenzi C, Giannace R, Marrelli D, Valentini M, Valensin PE.

Dig Liver Dis. 2000 Dec;32 Suppl 3:S182-3. No abstract available.

PMID:
11245289
20.

Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries.

Valassina M, Migliorini L, Sansoni A, Sani G, Corsaro D, Cusi MG, Valensin PE, Cellesi C.

J Med Microbiol. 2001 Mar;50(3):228-32.

PMID:
11232767
21.

Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.

Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert WJ.

Virus Res. 2001 Apr;74(1-2):133-7.

PMID:
11226581
22.

Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein.

Cusi MG, Valensin PE, Donati M, Valassina M.

J Med Virol. 2001 Jan;63(1):72-5.

PMID:
11130891
23.

Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

Cusi MG, Zurbriggen R, Valassina M, Bianchi S, Durrer P, Valensin PE, Donati M, Glück R.

Virology. 2000 Nov 10;277(1):111-8.

24.

Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy.

Romano L, Venturi G, Ferruzzi R, Riccio ML, Corsi P, Leoncini F, Vinattieri A, Incandela L, Valensin PE, Zazzi M.

AIDS. 2000 Sep 29;14(14):2204-6. No abstract available.

PMID:
11061664
25.

Expression of measles virus antigens in Streptococcus gordonii.

Maggi T, Oggioni MR, Medaglini D, Bianchi Bandinelli ML, Soldateschi D, Wiesmüller KH, Muller CP, Valensin PE, Pozzi G.

New Microbiol. 2000 Apr;23(2):119-28.

PMID:
10872681
26.

Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of HIV-1 RNA in plasma.

Venturi G, Ferruzzi R, Romano L, Catucci M, Valensin PE, Zazzi M.

J Virol Methods. 2000 Jun;87(1-2):91-7.

PMID:
10856756
27.

Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine.

Cusi MG, Lomagistro MM, Valassina M, Valensin PE, Glück R.

Vaccine. 2000 Jun 15;18(25):2838-42.

PMID:
10812227
28.

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.

Venturi G, Catucci M, Romano L, Corsi P, Leoncini F, Valensin PE, Zazzi M.

J Infect Dis. 2000 Feb;181(2):740-5.

PMID:
10669367
29.

Hepatitis C virus infection and myositis: a polymerase chain reaction study.

Villanova M, Caudai C, Sabatelli P, Toti P, Malandrini A, Luzi P, Maraldi NM, Valensin PE, Merlini L.

Acta Neuropathol. 2000 Mar;99(3):271-6.

PMID:
10663969
30.

Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy.

Catucci M, Venturi G, Romano L, Valensin PE, Zazzi M.

J Med Virol. 2000 Mar;60(3):294-9.

PMID:
10630962
31.

Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections.

Corsaro D, Valassina M, Venditti D, Venard V, Le Faou A, Valensin PE.

Diagn Microbiol Infect Dis. 1999 Oct;35(2):105-8.

PMID:
10579089
32.

Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus.

Valassina M, Meacci F, Valensin PE, Cusi MG.

J Med Virol. 2000 Jan;60(1):86-90.

PMID:
10568768
33.

Human herpesvirus 6 infection in autologous bone marrow transplant recipients: a prospective study.

Moschettini D, Galieni P, Valensin PE, Laszlo D, Scalia G, Tozzi M, Lauria F, Donati D.

J Med Virol. 2000 Jan;60(1):39-42.

PMID:
10568761
34.

Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors.

Catucci M, Venturi G, Romano L, Riccio ML, De Milito A, Valensin PE, Zazzi M.

J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):203-8.

PMID:
10421243
35.

Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.

Venturi G, Romano L, Catucci M, Riccio ML, De Milito A, Gonnelli A, Rubino M, Valensin PE, Zazzi M.

Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):274-82.

PMID:
10385016
36.

Peripheral neuropathy associated with anti-myelin basic protein antibodies in a woman vaccinated with rubella virus vaccine.

Cusi MG, Bianchi S, Santini L, Donati D, Valassina M, Valensin PE, Cioé L, Mazzocchio R.

J Neurovirol. 1999 Apr;5(2):209-14.

PMID:
10321986
37.

Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii.

Oggioni MR, Medaglini D, Romano L, Peruzzi F, Maggi T, Lozzi L, Bracci L, Zazzi M, Manca F, Valensin PE, Pozzi G.

AIDS Res Hum Retroviruses. 1999 Mar 20;15(5):451-9.

PMID:
10195755
38.

Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.

De Milito A, Catucci M, Venturi G, Romano L, Incandela L, Valensin PE, Zazzi M.

J Med Virol. 1999 Feb;57(2):140-4.

PMID:
9892398
39.

Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Zazzi M, Romano L, Catucci M, Venturi G, De Milito A, Valensin PE.

J Clin Microbiol. 1999 Feb;37(2):333-8.

40.

Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy.

Romano L, Venturi G, Catucci M, De Milito A, Valensin PE, Zazzi M.

J Infect Dis. 1999 Feb;179(2):361-6.

PMID:
9878019
41.

Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidasegene in wild-type strains of mumps virus is the most relevant marker of virulence.

Cusi MG, Santini L, Bianchi S, Valassina M, Valensin PE.

J Clin Microbiol. 1998 Dec;36(12):3743-4. No abstract available.

42.

Serological diagnosis of respiratory viral infections. A five-year study of hospitalised patients.

Donati D, Cellesi C, Rossolini A, Lorusso V, Moschettini D, Amato T, Valensin PE.

New Microbiol. 1998 Oct;21(4):365-74.

PMID:
9812318
43.

Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors.

Zazzi M, Riccio ML, Venturi G, Catucci M, Romano L, De Milito A, Valensin PE.

Mol Biotechnol. 1998 Aug;10(1):1-8.

PMID:
9779418
44.

Diagnostic potential of Toscana virus N protein expressed in Escherichia coli.

Valassina M, Soldateschi D, Dal Maso GM, Santini L, Bianchi S, Valensin PE, Cusi MG.

J Clin Microbiol. 1998 Nov;36(11):3170-2. Erratum in: J Clin Microbiol 1999 Apr;37(4):1237.

45.

Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons.

Caudai C, Padula MG, Bastianoni I, Valensin PE, Shyamala V, Han J, Boggiano CA, Almi P.

Infection. 1998 May-Jun;26(3):151-4.

PMID:
9646105
46.

Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method.

Moschettini D, De Milito A, Catucci M, Marconi A, Rinina C, Bianchi-Bandinelli ML, Valensin PE.

Eur J Clin Microbiol Infect Dis. 1998 Feb;17(2):117-9.

PMID:
9629978
47.

Detection of HCV and GBV-C/HGV infection by multiplex PCR in plasma samples of transfused subjects.

Caudai C, Padula MG, Bettini V, Valensin PE.

J Virol Methods. 1998 Jan;70(1):79-83.

PMID:
9506815
48.

Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.

Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C.

J Clin Microbiol. 1998 Jan;36(1):325-6. No abstract available.

49.

The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C.

Caudai C, Maimone D, Almi P, Annunziata P, Bastianoni I, Boggiano CA, Guazzi GC, Padula M, Valensin PE.

Gut. 1997 Sep;41(3):411-2.

50.

Rapid detection of different RNA respiratory virus species by multiplex RT-PCR: application to clinical specimens.

Valassina M, Cuppone AM, Cusi MG, Valensin PE.

Clin Diagn Virol. 1997 Nov;8(3):227-32.

PMID:
9406653

Supplemental Content

Loading ...
Support Center